EUVIMEDEUVIMED entdecken
Crossref

Sarsasapogenin attenuates renal ischemia-reperfusion injury by inhibiting the NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis

Qiang Yuan, Yaoke Li, Kaiwen Shen, Ruibo Zhang, Qiang Wang, Shasha Xia, Jun Shen

International Immunopharmacology · 2026-08 · 183 · 116872

DOI: 10.1016/j.intimp.2026.116872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-08. Verfasst von Qiang Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China. Hauptthemen laut MEDLINE: Reperfusion Injury, Spirostans, NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Renal ischemia-reperfusion injury (RIRI) contributes significantly to acute kidney injury (AKI), which is associated with high morbidity and mortality rates. Currently, therapeutic options for RIRI remain limited. Sarsasapogenin (Sar), a steroidal saponin from Anemarrhena asphodeloides, exhibits strong anti-inflammatory properties. However, its renoprotective effects, dose-response characteristics, and tissue-specific benefits in acute RIRI have not been thoroughly explored. This study aimed to determine whether Sar provides protection against RIRI-induced AKI and to investigate the potential signaling pathways involved. METHODS Rats underwent 45 min of renal ischemia followed by reperfusion. Sar (20 or 60 mg/kg) was administered daily via gavage for one week prior to surgery. As a positive control, INF39 (7.5 mg/kg), an NLRP3 inhibitor, was injected intraperitoneally 2 h before surgery. Renal function was assessed through serum creatinine and BUN levels, while histopathology was evaluated using H&E and TEM. Tubular injury markers, such as KIM-1, were also assessed. Total cell death was determined using the TUNEL assay, which detects DNA fragmentation but does not specifically identify pyroptosis. The expression of inflammatory factors (IL-1β, IL-6, TNF-α) and key proteins of the NF-κB pathway (p-p65/p65) and NLRP3 inflammasome (NLRP3, Caspase-1, GSDMD) were measured using ELISA, immunohistochemistry, immunofluorescence, and Western blotting. RESULTS RIRI led to severe renal dysfunction, structural damage, and increased KIM-1 expression. These pathological changes were linked to significant activation of the NF-κB pathway, upregulation of NLRP3 inflammasome components, and increased pyroptosis, indicated by elevated levels of cleaved Caspase-1, GSDMD-N, and mature IL-1β. Pretreatment with Sar dose-dependently improved renal function and reduced histopathological injury. Sar provided tissue-specific protection by maintaining mitochondrial integrity in renal tubular epithelial cells. These beneficial effects were accompanied by decreased phosphorylation of p65, reduced expression of NLRP3, cleaved Caspase-1, and GSDMD-N, as well as lower IL-1β production. High-dose Sar exhibited renoprotective effects comparable to INF39, acting as a multi-stage regulator that inhibits both NF-κB priming and NLRP3 inflammasome activation, suggesting advantages over single-target inhibitors. CONCLUSION Sar effectively attenuated RIRI-induced AKI, demonstrating favorable dose-dependent and tissue-specific renoprotective effects. This protective effect was associated with suppression of the NF-κB/NLRP3 inflammasome axis and reduced pyroptosis, highlighting its potential as a safe, multi-stage, natural candidate for treating ischemia-related renal injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjurySpirostansNLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BInflammasomesAcute Kidney InjuryAnti-Inflammatory AgentsAnimalsMaleRats, Sprague-DawleySignal TransductionRatsPyroptosisKidney

Stichwörter der Autor:innen

Acute kidney injuryNF-κBNLRP3 inflammasomePyroptosisRenal ischemia-reperfusion injurySarsasapogenin

Substanzen

SpirostansNLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BInflammasomessarsasapogeninNlrp3 protein, ratAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Urology Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China.
  • Department of Urology Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guizhou Hospital, Guiyang, Guizhou 550000, PR China.
  • Department of Urology Surgery, Guiqian International Hospital, Guiyang, Guizhou 550018, PR China.
  • Department of Interventional Vascular Surgery, Tongren People's Hospital, Tongren, Guizhou 554300, PR China.
  • Department of Urology Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China; Department of Urology Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guizhou Ho…

Zitieren

APA

Yuan, Q., Li, Y., Shen, K., Zhang, R., Wang, Q., Xia, S., & Shen, J. (2026). Sarsasapogenin attenuates renal ischemia-reperfusion injury by inhibiting the NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis. International Immunopharmacology, 183, 116872. https://doi.org/10.1016/j.intimp.2026.116872

Vancouver

Yuan Q, Li Y, Shen K, Zhang R, Wang Q, Xia S, et al. Sarsasapogenin attenuates renal ischemia-reperfusion injury by inhibiting the NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis. International Immunopharmacology. 2026;183:116872. doi:10.1016/j.intimp.2026.116872

BibTeX
@article{Yuan2026,
  author = {Yuan, Qiang and Li, Yaoke and Shen, Kaiwen and Zhang, Ruibo and Wang, Qiang and Xia, Shasha and Shen, Jun},
  title = {Sarsasapogenin attenuates renal ischemia-reperfusion injury by inhibiting the NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {183},
  pages = {116872},
  doi = {10.1016/j.intimp.2026.116872}
}
Kostenlos starten →